HRT Financial’s CytoMed Therapeutics GDTC Stock Holding History
Bought
Maintained
Sold
Other funds holding GDTC
HRT Financial's GDTC Position: Q3 2026 in Review
HRT Financial opened a new position in CytoMed Therapeutics (GDTC) in Q3 2026: 25,636 shares worth $21K. The stake represents ﹤0.01% of the portfolio and ranks #4489 among its holdings.
6 funds tracked by Wall St. Rank hold GDTC as of Q3 2026.
- HRT Financial held 25,636 shares of CytoMed Therapeutics worth $21K as of Q3 2026.
- CytoMed Therapeutics was a new HRT Financial position in Q3 2026.
- CytoMed Therapeutics made up ﹤0.01% of HRT Financial's portfolio in Q3 2026, its #4489 holding.
- 6 funds tracked by Wall St. Rank held CytoMed Therapeutics as of Q3 2026.
Based on HRT Financial's 13F filing for Q3 2026, filed 13 Nov 2026.